MEDICAL COLLEGE OF GEORGIA AT AUGUSTA UNIVERSITY IMAGE: A HIGH-RESOLUTION PHOTO OF (FROM LEFT) DRS. BABAK BABAN, JOHN MORGAN AND HESAM KHODADADI. CREDIT: KIM RATLIFF, AUGUSTA UNIVERSITY PHOTOGRAPHER A two-week course of high doses of CBD helps restore the function of two proteins key to reducing the accumulation of beta-amyloid plaque, a hallmark of Alzheimer’s...
ROCKEFELLER UNIVERSITY PRESS IMAGE: Compared with a control (left), treatment with the novel GSM (right) reduces the number of amyloid plaques (green) and proinflammatory cells called microglia (magenta) in the brains of mice carrying mutations linked to early-onset Alzheimer’s disease. CREDIT: ©2021 RYNEARSON ET AL. ORIGINALLY PUBLISHED IN JOURNAL OF EXPERIMENTAL MEDICINE. HTTPS://DOI.ORG/10.1084/JEM.20202560 Researchers at the University of...
Researchers at University of California San Diego School of Medicine have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia. The protein,...
by West Virginia University A new study by Rashi Mehta—a researcher with the WVU School of Medicine and Rockefeller Neuroscience Institute—finds that focused ultrasound may induce an immunological healing effect in the brains of Alzheimer’s patients. Credit: Caylie Silveria/West Virginia University West Virginia University scientists used MRI scans to show what happens when ultrasound waves target...
by IOS Press Credit: Pixabay/CC0 Public Domain Early diagnosis of Alzheimer’s disease has been shown to reduce cost and improve patient outcomes, but current diagnostic approaches can be invasive and costly. A recent study, published in the Journal of Alzheimer’s Disease, has found a novel way to identify a high potential for developing Alzheimer’s disease before symptoms...
by CHeBA Credit: Unsplash/CC0 Public Domain Australian researchers have shown that a dietary supplement that increases the levels of a powerful antioxidant in the brain may represent a novel strategy for the treatment and/or prevention of cognitive impairment and debilitating neurodegenerative diseases such as Alzheimer’s disease. Findings of the study were recently published in Neurochemistry International....
Findings from a new study on Alzheimer’s disease (AD), led by researchers at the University of Saskatchewan (USask), could eventually help clinicians identify people at highest risk for developing the irreversible, progressive brain disorder and pave the way for treatments that slow or prevent its onset. Image credit: Pixabay (Free Pixabay license) The research, published in the journal Scientific Reports in...
by Uppsala University Credit: CC0 Public Domain Higher blood pressure at night than in daytime may be a risk factor for Alzheimer’s disease in older men, according to a new study from researchers at Uppsala University, now published in the journal Hypertension. Dementia is an umbrella term used to describe a category of symptoms marked by behavioural changes and...
by New York University The compound ISRIB shrank plaques in the brain in a mouse model of Alzheimer’s disease (right, rectangle). Credit: M.M. Oliveira et al., Science Signaling (2021) A team of neuroscientists has identified a potential means to address the loss of cognitive function due to Alzheimer’s disease by targeting protein synthesis in mice. Their...
IBM researchers trained artificial intelligence to pick up hints of changes in language ahead of the onset of neurological diseases. An M.R.I. scan of a patient over the age of 60 with Alzheimer’s disease.Credit…Zephyr/Science Source By Gina Kolata Feb. 1, 2021, 10:41 a.m. ET Is it possible to predict who will develop Alzheimer’s disease simply by looking...
